The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.50
Bid: 100.00
Ask: 105.00
Change: 8.50 (9.04%)
Spread: 5.00 (5.00%)
Open: 97.00
High: 102.50
Low: 100.50
Prev. Close: 94.00
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Jan 2017 15:05

12 January 2017

ECO Animal Health Group plc ("ECO" or the "Company")

Director / PDMR Shareholding and Notification

The Company was notified today by Peter Lawrence, a director of the Company, of the transfer of an aggregate of 278,951 ordinary shares of 5 pence each in the Company ("Ordinary Shares") to his children, Michael Lawrence (214,473 Ordinary Shares yesterday) and Louise Lawrence (64,478 Ordinary Shares today) all at nil cost. Subsequently, Michael Lawrence sold 150,000 Ordinary shares at £5.10 today to satisfy institutional demand.

Following this transfer and sale, Peter Lawrence and his family's beneficial interests in the Company is 9,648,477 Ordinary Shares representing 14.8% of the Company voting rights.

Enquiries:

ECO Animal Health Group plc 020 8447 8899
Marc Loomes
Julia Trouse 020 8336 6184
Spiro Financial 020 8336 6196
Anthony Spiro
Peel Hunt LLP 020 7418 8900
Dan Webster, Adrian Trimmings, George Sellar

PDMR notification

1a) Name: Peter Lawrence, Michael Lawrence, Louise Lawrence
2 Reason for the notification
a) Position/Status Chairman
b) Initial notification/ Amendment Initial notification
3a) Name: ECO Animal Health Group plc
3b) LEI 01818170
4a) Description of the financial instrument, type of instrument Ordinary shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
4b) Nature of transaction Transfer and sale of ordinary shares
4c) Prices and volumes Transfer of 214,473 ordinary shares at nil cost 11-1-17

Transfer of 64,478 ordinary shares at nil cost 12-1-17

Sale of 150,000 ordinary shares at £5.10 12-1-17

4d) Aggregate information Transfer 278,951 ordinary shares at nil cost
Aggregate volume and price Sale 150,000 ordinary shares at £5.10
4e) Date of transaction As above, 11-1-17 and 12-1-17 GMT
4f) Place of the transaction London Stock Exchange (XLON), AIM market

View source version on businesswire.com: http://www.businesswire.com/news/home/20170112005654/en/

Copyright Business Wire 2017

Date   Source Headline
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.